Search

Search Constraints

You searched for: Author/Creator Boz, Cavit

Search Results

1. 004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis. (23rd August 2021)

2. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. (5th September 2017)

3. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. (14th June 2022)

4. Comparative effectiveness in multiple sclerosis: A methodological comparison. (March 2023)

5. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis. (August 2015)

6. Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Issue 2 (April 2016)

7. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. Issue 12 (19th October 2022)

8. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Issue 4 (13th January 2019)

9. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

10. Contribution of different relapse phenotypes to disability in multiple sclerosis. (February 2017)